8-K: My Size Secures $10M Equity Line with Square Gate Capital

My Size, Inc. has entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC Series 5, allowing for the sale of up to $10 million in common stock over 36 months.

Summary

• My Size, Inc. has entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC Series 5.
• The agreement allows My Size to sell up to $10 million of its common stock to the investor over a 36-month period.
• The company has the discretion to initiate sales by delivering a 'Put Notice'.
• Sales are subject to a 4.99% ownership limit per transaction and an overall Exchange Cap of 19.99% of outstanding shares, unless stockholder approval is obtained or the average sale price exceeds $0.3706.
• The purchase price is generally set at 96.5% of the lowest daily VWAP for regular sales or 100% of the lowest traded price for intraday sales.
• My Size paid a $100,000 commitment fee in the form of 269,229 shares of common stock.
• The company has agreed to file a registration statement for the resale of these shares.
• Restrictions are in place that may limit the company's ability to raise additional capital through equity financings during the agreement's term.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the dilutive nature of the equity purchase agreement and the potential for significant share price impact, despite the flexibility it offers for capital raising.

Positives

• Provides access to up to $10 million in capital over 36 months, offering financial flexibility.
• The company retains the sole discretion to decide when to sell shares, allowing for strategic timing.
• The agreement includes provisions for an 'Average Price' threshold ($0.3706) that could allow for sales exceeding the initial Exchange Cap without stockholder approval.
• The investor is prohibited from engaging in short sales or hedging transactions related to the company's stock.

Negatives

• The agreement is dilutive, as it allows for the sale of up to $10 million worth of common stock.
• The purchase price is set at a discount to market prices (96.5% of VWAP for regular sales), which can negatively impact existing shareholders.
• The Exchange Cap of 19.99% could be exceeded, leading to significant dilution if stockholder approval is not obtained or the average price condition is not met.
• Restrictions on other equity financings and variable rate transactions during the agreement's term could limit future capital-raising options.

Risks

• Potential for significant dilution of existing shareholders' equity if the company utilizes the full $10 million commitment, especially if the stock price is low.
• The company's ability to raise additional capital through equity financings may be restricted during the term of the agreement due to standstill provisions.
• The market price of the common stock could be negatively impacted by the ongoing ability of the company to sell shares to the investor.
• The effectiveness of the registration statement and the eligibility for resale of commitment shares could impact the company's obligations regarding 'True-Up Commitment Shares'.

Future Outlook

The company has the right, but not the obligation, to sell up to $10 million of its common stock to the investor over the next 36 months. Actual sales will depend on market conditions, the stock price, and the company's funding needs. Proceeds are intended for working capital and general corporate purposes.

Management Comments

• Actual sales of shares of our common stock, if any, to the Investor under the Equity Purchase Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Companys common stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

Industry Context

StockSavvy.ai notes that equity purchase agreements, often referred to as 'at-the-market' or 'equity lines,' are common financing tools for smaller public companies seeking flexible access to capital. However, they often come with dilutive terms and can signal financial pressure to the market.

Stakeholder Impact

• Shareholders: Potential for dilution of ownership and earnings per share if the company sells a significant number of shares, especially at prices below current market value.
• Creditors: May view the equity line as a sign of financial need, potentially impacting creditworthiness, though it provides a source of funds for operations.
• Management: Gains flexibility in accessing capital but faces the challenge of managing dilution and market perception.

Next Steps

• The company must submit an initial registration statement on Form S-1 to the SEC within 30 calendar days of the Registration Rights Agreement.
• The company must use commercially reasonable efforts to cause the Registration Statement to be declared effective by the SEC.
• The company may initiate sales of shares to the investor by delivering a 'Put Notice' on any trading day.
• The company must comply with standstill provisions that may restrict further equity financings during certain periods.

Key Dates

Recommendation

The equity purchase agreement provides a potential source of capital, which is positive for operational flexibility. However, the dilutive nature of the agreement, the discount to market price, and the potential for significant share issuance warrant caution. Existing shareholders should monitor the company's utilization of this facility and its impact on share price and ownership.

Keywords

Equity Purchase Agreement, Capital Raise, Common Stock, Dilution, Registration Rights, Working Capital, General Corporate Purposes, Accredited Investor